| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Friday, August 07, 2026 10:27 AM
Latigo Biotherapeutics (LTGO) stock surges after the company priced an upsized initial public offering of 19.2M shares at $18 each. Read more here.
|
|
Friday, August 07, 2026 03:17 AM
Latigo Biotherapeutics increased its initial public offering to 19.2 million shares for $18 apiece. The clinical-stage biopharmaceutical company previously planned to sell 16 million shares at between ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/08/26 | 18.10 | 18.9983 | 17.2201 | 18.56 | 598,429 |
|
|
||||
|
|
||||
|
|